Cargando…
813. Combination of N-Acetyl-Cysteine With Clarithromycin Against Mycobacterium avium Infection
BACKGROUND: N-Acetyl-cysteine (NAC) is widely used in patients with chronic pulmonary diseases. In previous studies, its antimicrobacterial and antimycobacterial effects have been reported. Among its effect in Mycobacteria, it has been mainly studied in Mycobacterium tuberculosis. Here, we examined...
Autores principales: | Shiozawa, Ayako, Kajiwara, Chiaki, Ishii, Yoshikazu, Tateda, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254830/ http://dx.doi.org/10.1093/ofid/ofy210.820 |
Ejemplares similares
-
Is the information on infection prevention measures against COVID-19 reaching the target audience? A cross-sectional survey among eating and drinking services in Tokyo, Japan
por: Shiozawa, Ayako, et al.
Publicado: (2023) -
Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
por: Kim, Eun Young, et al.
Publicado: (2011) -
Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease
por: Shimomura, Hitoshi, et al.
Publicado: (2015) -
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease
por: Kadota, Tsukasa, et al.
Publicado: (2016) -
A Novel Approach to Extensive Clarithromycin- Resistant Mycobacterium avium Complex Pulmonary Disease
por: Togo, Takeo, et al.
Publicado: (2021)